Scientists have shown that human cells can be reprogrammed to grow sheets of corneal tissue, and that stem cells in the human eye can be coaxed to regrow clear lenses after cataract surgery.

Acucela Inc. and YouHealth Eyetech Inc. have signed an agreement to develop a pharmacologic treatment for cataracts.

Two late-stage trials identify safety issues for Aerie Pharmaceuticals new glaucoma treatment, Rhopressa.

Ruling out glaucoma in myopic eyes often poses a diagnostic challenge because of atypical optic disc morphology and visual field defects that can mimic glaucoma. We determined whether neuroretinal rim assessment based on Bruch's membrane opening (BMO), rather than conventional optic disc margin (DM)-based assessment or retinal nerve fiber layer (RNFL) thickness, yielded higher diagnostic accuracy in myopic patients with glaucoma.

To map the 3-dimensional (3D) strain of the optic nerve head (ONH) in vivo after intraocular pressure (IOP) lowering by trabeculectomy (TE) and to establish associations between ONH strain and retinal sensitivity.

To explore the visual acuity and anatomic outcomes over 24 months of patients with diabetic macular edema (DME) who showed a delayed anatomic response after 3 ranibizumab injections in the RIDE and RISE trials.